05:34 PM EDT, 08/19/2025 (MT Newswires) -- Yvonne Greenstreet, Director, Chief Executive Officer, on August 15, 2025, sold 6,979 shares in Alnylam Pharmaceuticals ( ALNY ) for $3,163,346. Following the Form 4 filing with the SEC, Greenstreet has control over a total of 56,628 common shares of the company, with 56,221 shares held directly and 407 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1178670/000173527625000089/xslF345X05/edgardoc.xml